Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 120

Similar articles for PubMed (Select 22836051)

1.

Higher levels of c-Met expression and phosphorylation identify cell lines with increased sensitivity to AMG-458, a novel selective c-Met inhibitor with radiosensitizing effects.

Li B, Torossian A, Sun Y, Du R, Dicker AP, Lu B.

Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):e525-31. doi: 10.1016/j.ijrobp.2012.06.025. Epub 2012 Jul 24.

PMID:
22836051
2.

C-Met inhibitor MK-8003 radiosensitizes c-Met-expressing non-small-cell lung cancer cells with radiation-induced c-Met-expression.

Bhardwaj V, Zhan Y, Cortez MA, Ang KK, Molkentine D, Munshi A, Raju U, Komaki R, Heymach JV, Welsh J.

J Thorac Oncol. 2012 Aug;7(8):1211-7. doi: 10.1097/JTO.0b013e318257cc89.

3.

Radiosensitizing effect of YM155, a novel small-molecule survivin suppressant, in non-small cell lung cancer cell lines.

Iwasa T, Okamoto I, Suzuki M, Nakahara T, Yamanaka K, Hatashita E, Yamada Y, Fukuoka M, Ono K, Nakagawa K.

Clin Cancer Res. 2008 Oct 15;14(20):6496-504. doi: 10.1158/1078-0432.CCR-08-0468.

4.

AT-101, a pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer.

Moretti L, Li B, Kim KW, Chen H, Lu B.

J Thorac Oncol. 2010 May;5(5):680-7. doi: 10.1097/JTO.0b013e3181d6e08e.

PMID:
20354451
5.

Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.

Ma PC, Jagadeeswaran R, Jagadeesh S, Tretiakova MS, Nallasura V, Fox EA, Hansen M, Schaefer E, Naoki K, Lader A, Richards W, Sugarbaker D, Husain AN, Christensen JG, Salgia R.

Cancer Res. 2005 Feb 15;65(4):1479-88.

6.

Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.

De Bacco F, Luraghi P, Medico E, Reato G, Girolami F, Perera T, Gabriele P, Comoglio PM, Boccaccio C.

J Natl Cancer Inst. 2011 Apr 20;103(8):645-61. doi: 10.1093/jnci/djr093. Epub 2011 Apr 4.

7.

A selective small molecule c-MET Inhibitor, PHA665752, cooperates with rapamycin.

Ma PC, Schaefer E, Christensen JG, Salgia R.

Clin Cancer Res. 2005 Mar 15;11(6):2312-9.

9.

Molecular predictors of sensitivity to the MET inhibitor PHA665752 in lung carcinoma cells.

Matsubara D, Ishikawa S, Oguni S, Aburatani H, Fukayama M, Niki T.

J Thorac Oncol. 2010 Sep;5(9):1317-24. doi: 10.1097/JTO.0b013e3181e2a409.

PMID:
20736805
10.

Inhibition of PI3 kinases enhances the sensitivity of non-small cell lung cancer cells to ionizing radiation.

Zhang T, Cui GB, Zhang J, Zhang F, Zhou YA, Jiang T, Li XF.

Oncol Rep. 2010 Dec;24(6):1683-9.

PMID:
21042768
11.

Inhibition of tumor growth and metastasis in non-small cell lung cancer by LY2801653, an inhibitor of several oncokinases, including MET.

Wu W, Bi C, Credille KM, Manro JR, Peek VL, Donoho GP, Yan L, Wijsman JA, Yan SB, Walgren RA.

Clin Cancer Res. 2013 Oct 15;19(20):5699-710. doi: 10.1158/1078-0432.CCR-13-1758. Epub 2013 Aug 29.

12.
13.

Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level.

Chen S, Wang H, Ng WL, Curran WJ, Wang Y.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1524-9. doi: 10.1016/j.ijrobp.2011.05.031. Epub 2011 Oct 17.

PMID:
22014955
14.

Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.

Nagata Y, Takahashi A, Ohnishi K, Ota I, Ohnishi T, Tojo T, Taniguchi S.

Int J Oncol. 2010 Oct;37(4):1001-10.

PMID:
20811722
15.

Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival.

Lutterbach B, Zeng Q, Davis LJ, Hatch H, Hang G, Kohl NE, Gibbs JB, Pan BS.

Cancer Res. 2007 Mar 1;67(5):2081-8. Erratum in: Cancer Res. 2007 Apr 15;67(8):3987.

16.

Targeting epidermal growth factor receptor-associated signaling pathways in non-small cell lung cancer cells: implication in radiation response.

Choi EJ, Ryu YK, Kim SY, Wu HG, Kim JS, Kim IH, Kim IA.

Mol Cancer Res. 2010 Jul;8(7):1027-36. doi: 10.1158/1541-7786.MCR-09-0507. Epub 2010 Jun 29.

18.

MET tyrosine kinase inhibitor crizotinib (PF-02341066) shows differential antitumor effects in non-small cell lung cancer according to MET alterations.

Tanizaki J, Okamoto I, Okamoto K, Takezawa K, Kuwata K, Yamaguchi H, Nakagawa K.

J Thorac Oncol. 2011 Oct;6(10):1624-31. doi: 10.1097/JTO.0b013e31822591e9.

PMID:
21716144
19.

NS398 induces apoptosis in non-small cell lung cancer cells.

Qiu R, Chen J, Sima J, Shen X, Liu D, Shen J.

J Cancer Res Clin Oncol. 2012 Jan;138(1):119-24. doi: 10.1007/s00432-011-1080-3. Epub 2011 Nov 3.

PMID:
22048655
20.

Effect of PF-02341066 and radiation on non-small cell lung cancer cells.

Tumati V, Kumar S, Yu L, Chen B, Choy H, Saha D.

Oncol Rep. 2013 Mar;29(3):1094-100. doi: 10.3892/or.2012.2198. Epub 2012 Dec 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk